Specifically, Gong et al. [16] demonstrated improved glucose metabolism and insulin sensitivity with PBM therapy, by activating CCO-protein kinase B in the muscles of T2DM mice. This evidence concerns the gene RYR1 and type 2 diabetes mellitus.